Article Details
Retrieved on: 2018-02-14 03:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... financial interest in the securities of Rexahn Pharmaceuticals, Inc. (including, without limitation, any option, right, warrant, future, long or short position). As of Jan. 31, 2018 neither the Firm nor its affiliates beneficially own 1% or more of any class of common <b>equity securities</b> of Rexahn Pharmaceuticals, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here